Shopping Cart
- Remove All
Your shopping cart is currently empty
EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $8,290 | 6-8 weeks | |
| 50 mg | $11,700 | 6-8 weeks | |
| 100 mg | $16,400 | 6-8 weeks |
| Description | EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist. |
| Molecular Weight | 318.3 |
| Formula | C16H13F3N4 |
| Cas No. | 627525-33-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.